Related Experiment Video
Updated: Jan 9, 2026

Phage Phenomics: Physiological Approaches to Characterize Novel Viral Proteins
Published on: June 11, 2015
AI-Driven Structural Elucidation of the Bacteriophage KP32: Decoding Its Molecular Arsenal Against Klebsiella
Mario Privitera1,2, Giovanni Barra1, Flavia Squeglia1
1Institute of Biostructures and Bioimaging, National Research Council, 80131 Naples, Italy.
Background:
Klebsiella pneumoniae is one of the most critical Gram-negative bacteria according to the World Health Organization (WHO). Due to the ability of this bacterium to evade antibiotics, phage therapy is becoming a promising tool. However, the use of isolated proteins rather than entire phages could reduce several risks associated with phage replication. Thus, understanding the protein composition and structural organization of bacteriophages is crucial for unlocking their biology and holds great potential for medicine and biotechnology.
Methods:
In this study, artificial intelligence with AlphaFold 3.0 (AF3) and bioinformatic analysis were used to model the hitherto unknown structure of the Klebsiella phage KP32 (KP32), a complex and selective phage that targets K. pneumoniae strains with the K3 and K21/KL163 capsular serotypes.
Results:
By combining AF3 with sequence and structure analysis, we reconstructed the entire phage KP32. This complex phage is composed of over 500 protein chains, of which 415 compose its capsid and 104 its core-portal-tail complex, a platform that allows the phage to adhere to K. pneumoniae, hydrolyze its capsular sugars and finally inject its genetic code into the bacterium.
Conclusions:
Phage therapy is a potentially promising tool for controlling antimicrobial resistance (AMR). However, one limitation arises from the limited knowledge of their nature and mechanisms of action, as only a few phages have been structurally characterized. The reconstruction of entire phages is currently a viable strategy for elucidating their mechanistic properties, knowledge that will enhance their potential applications as therapeutic alternatives.
Insights
Researchers used AI to model the Klebsiella phage KP32 structure, revealing its protein composition. This breakthrough advances phage therapy for combating antibiotic-resistant Klebsiella pneumoniae.
Area of Science:
- Structural biology
- Bioinformatics
- Microbiology
Background:
- Klebsiella pneumoniae is a critical Gram-negative bacterium identified by the WHO.
- Phage therapy presents a promising alternative to antibiotics due to K. pneumoniae's resistance.
- Understanding bacteriophage structure is vital for their application in medicine and biotechnology.
Purpose of the Study:
- To model the structure of Klebsiella phage KP32 (KP32) using artificial intelligence.
- To elucidate the protein composition and structural organization of KP32.
- To advance the understanding of bacteriophages for potential therapeutic applications.
Main Methods:
- Utilized artificial intelligence with AlphaFold 3.0 (AF3) for structural modeling.
- Employed bioinformatic analysis for sequence and structure assessment.
- Reconstructed the entire structure of Klebsiella phage KP32.
Main Results:
- The complete structure of phage KP32 was reconstructed, comprising over 500 protein chains.
- The capsid is formed by 415 protein chains.
- A core-portal-tail complex (104 proteins) facilitates adherence, capsular hydrolysis, and genetic injection into K. pneumoniae.
Conclusions:
- Structural characterization of bacteriophages is limited, hindering phage therapy.
- Reconstructing entire phages is a viable strategy to understand their mechanisms.
- This knowledge enhances the potential of phage therapy for combating antimicrobial resistance (AMR).
Related Concept Videos
DNA Bacteriophages
Viral Replication: Lytic Cycle
Lytic Cycle of Bacteriophages
Lysogenic Cycle of Bacteriophages
CRISPR and crRNAs
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
Viral Replication: Lysogenic Cycle

